Stoke Therapeutics, Inc. (STOK) Return on equity 2022–2025
Stoke Therapeutics, Inc. (STOK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2.0%FY2025 · since FY2022: -54.7% → -2.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.0% | +36.9 pp |
| FY2024 | -38.9% | +26.8 pp |
| FY2023 | -65.6% | -10.9 pp |
| FY2022 | -54.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice